|
1
|
Raggatt LJ and Partridge NC: Cellular and
molecular mechanisms of bone remodeling. J Biol Chem.
285:25103–25108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weitzmann MN and Pacifici R: Estrogen
deficiency and bone loss: An inflammatory tale. J Clin Invest.
116:1186–1194. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnell O and Kanis JA: An estimate of the
worldwide prevalence and disability associated with osteoporotic
fractures. Osteoporos Int. 17:1726–1733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boyce BF, Yoneda T and Guise TA: Factors
regulating the growth of metastatic cancer in bone. Endocr Relat
Cancer. 6:333–347. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mundy GR: Metastasis to bone: Causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roodman CD: Mechanism of bone metastasis.
N Engl J Med. 350:1655–1664. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Akhtari M, Mansuri J, Newman KA, Guise TM
and Seth P: Biology of brest cancer bone metastasis. Cancer Biol
Ther. 7:3–9. 2008. View Article : Google Scholar
|
|
8
|
Coleman RE: Metastatic bone disease:
Clinical features, pathophysiology and treatment strategies. Cancer
Treat Rev. 27:165–176. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen YC, Sosnoski DM and Mastro AM: Breast
cancer metastasis to the bone: mechanisms of bone loss. Breast
Cancer Res. 12:2152010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park BK, Zhang H, Zeng Q, Dai J, Keller
ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, et al: NF-κB in
breast cancer cells promotes osteolytic bone metastasis by inducing
osteoclastogenesis via GM-CSF. Nat Med. 13:62–69. 2007. View Article : Google Scholar
|
|
11
|
Gonzalez-Suarez E, Jacob AP, Jones J,
Miller R, Roudier-Meyer MP, Gonzalez-Suarez E, Jacob AP, Jones J,
Miller R, Roudier-Meyer MP, et al: RANK ligand mediates
progestin-induced mammary epithelial proliferation and
carcinogenesis. Nature. 468:103–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zaidi M, Blair HC, Moonga BS, Abe E and
Huang CL: Osteoclastogenesis, bone resorption, and osteoclast-based
therapeutics. J Bone Miner Res. 18:599–609. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weilbaecher KN, Guise TA and McCauley LK:
Cancer to bone: A fatal attraction. Nat Rev Cancer. 11:411–425.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lai YL and Yamaguchi M: Phytocomponent
p-hydroxycinnamic acid stimulates bone formation and inhibits bone
resorption in rat femoral tissues in vitro. Mol Cell Biochem.
292:45–52. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamaguchi M, Lai YL, Uchiyama S and
Nakagawa T: Phytocomponent p-hydroxycinnamic acid stimulates
mineralization in osteoblastic MC3T3-E1 cells. Int J Mol Med.
22:287–291. 2008.PubMed/NCBI
|
|
16
|
Lai YL and Yamaguchi M: Phytocomponent
p-hydroxycinnamic acid inhibits osteoclast-like cell formation in
mouse bone marrow cultures. Int J Mol Med. 19:123–128. 2007.
|
|
17
|
Yamaguchi M and Weitzmann MN: The bone
anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast
mineralization and suppresses osteoclast differentiation by
antagonizing NF-κB activation. Int J Mol Med. 30:708–712.
2012.PubMed/NCBI
|
|
18
|
Yamaguchi M, Lai YL, Uchiyama S and
Nakagawa T: Oral administration of phytocomponent p-hydroxycinnamic
acid prevents bone loss in ovariectomized rats. Mol Cell Biochem.
311:31–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamaguchi M, Uchiyama S and Lai YL: Oral
administration of phytocom ponent p-hydroxycinnamic acid has a
preventive effect on bone loss in streptozotocin-induced diabetic
rats. Int J Mol Med. 19:803–807. 2007.PubMed/NCBI
|
|
20
|
Yamaguchi M, Baile CA, Zhu S and Shoji M:
Bioactive flavonoi p-hydroxycinnamic acid stimulates
osteoblastogenesis and suppresses adipogenesis in bone marrow
culture. Cell Tissue Res. 354:743–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamaguchi M, Zhu S, Weitzman MN, Snyder JP
and Shoji M: Curcumin analog UBS109 prevents bone marrow
osteoblastogenesis and osteoclastogenesis disordered by coculture
with breast cancer MDA-MB-231 bone metastatic cells in vitro. Mol
Cell Biochem. 401:1–10. 2015. View Article : Google Scholar
|
|
22
|
Yoneda T, Williams PJ, Hiraga T, Niewolna
M and Nishimura R: A bone-seeking clone exhibits different
biological properties from the MDA-MB-231 parental human breast
cancer cells and a brain-seeking clone in vivo and in vitro. J Bone
Miner Res. 16:1486–1495. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yamaguchi M and Daimon Y: Overexpression
of regucalcin suppresses cell proliferation in cloned rat hepatoma
H4-II-E cells: Involvement of intracellular signaling factors and
cell cycle-related genes. J Cell Biochem. 95:1169–1177. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamaguchi M: The anti-apoptotic effect of
regucalcin is mediated through multisignaling pathways. Apoptosis.
18:1145–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Misawa H, Inagaki S and Yamaguchi M:
Suppression of cell proliferation and deoxyribonucleic acid
synthesis in cloned rat hepatoma H4-II-E cells overexpressing
regucalcin. J Cell Biochem. 84:143–149. 2002. View Article : Google Scholar
|
|
26
|
Minkin C: Bone acid phosphatase:
Tartrate-resistant acid phosphatase as a marker osteoclast
function. Calcif Tissue Int. 34:285–290. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meijer L, Borgne A, Mulner O, Chong JP,
Blow JJ, Inagaki N, Inagaki M, Deleros JG and Moulinoux JP:
Biochemical and cellular effects of roscovitine, a potent and
selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and
cdk5. Eur J Biochem. 243:527–536. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh SV, Herman-Antosiewicz A, Singh AV,
Lew KL, Srivastava SK, Kamath R, Brown KD, Zhang L and Baskaran R:
Sulforaphane-induced G2/M phase cell cycle arrest involves
checkpoint kinase 2-mediated phosphorylation of cell division cycle
25C. J Biol Chem. 279:25813–25822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y, Li A, Strait K, Zhang H, Nanes MS
and Weitzmann MN: Endogenous TNFalpha lowers maximum peak bone mass
and inhibits osteoblastic Smad activation through NF-kappaB. J Bone
Miner Res. 22:646–655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cano-Abad MF, Villarroya M, Garcia AG,
Gabilan NH and Lopez MG: Calcium entry through L-type calcium
channels causes mitochondrial disruption and chromaffin cell death.
J Biol Chem. 276:39695–39704. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen S, Wang Y, Ruan W, Wang X and Pan C:
Reversing multidrug resistance in hepatocellular carcinoma cells by
inhibiting extra-cellular signal-regulated kinase/mitogen-activated
protein kinase signaling pathway activity. Oncol Lett. 8:2333–2339.
2014.PubMed/NCBI
|
|
32
|
Chen QW, Edvinsson L and Xu CB: Role of
ERK/MAPK in endothelin receptor signaling in human aortic smooth
muscle cells. BMC Cell Biol. 10:522009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Serrano-Nascimento C, da Silva Teixeira S,
Nicola JP, Nachbar RT, Masini-Repiso AM and Nunes MT: The acute
inhibitory effect of iodide excess on sodium/iodide symporter
expression and activity involves the PI3K/Akt signaling pathway.
Endocrinology. 155:1145–1156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Palangat M, Grass JA, Langelier MF,
Coulombe B and Landick R: The RPB2 flap loop of human RNA
polymerase II is dispensable for transcription initiation and
elongation. Mol Cell Biol. 31:3312–3325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tang SC and Chen YC: Novel therapeutic
targets for pancreatic cancer. World J Gastroenterol.
20:10825–10844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Muruganandan S, Roman AA and Sinal CJ:
Adipocyte differentiation of bone marrow-derived mesenchymal stem
cells: cross talk with the osteoblastogenic program. Cell Mol Life
Sci. 66:236–253. 2009. View Article : Google Scholar
|
